Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Cetuximab in the treatment of rheumatoid arthritis.

Sullivan T, Benjamin CG, Kempf PW, Deeken JF.

J Clin Rheumatol. 2010 Jan;16(1):32-3. doi: 10.1097/RHU.0b013e3181c8e176.

PMID:
20051754
2.

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU; GO-AFTER study investigators.

Lancet. 2009 Jul 18;374(9685):210-21. doi: 10.1016/S0140-6736(09)60506-7. Epub 2009 Jun 26. Erratum in: Lancet. 2009 Oct 24;374(9699):1422.

PMID:
19560810

Supplemental Content

Loading ...
Write to the Help Desk